Exane Derivatives’s Mettler-Toledo International MTD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$474K Buy
413
+59
+17% +$74.1K 0.27% 91
2022
Q1
$486K Sell
354
-94
-21% -$136K 0.14% 191
2021
Q4
$760K Buy
448
+116
+35% +$175K 0.18% 123
2021
Q3
$457K Sell
332
-22
-6% -$33.1K 0.11% 204
2021
Q2
$511K Sell
354
-36
-9% -$46.4K 0.12% 177
2021
Q1
$451K Sell
390
-12
-3% -$13.9K 0.13% 161
2020
Q4
$458K Sell
402
-74
-16% -$81.1K 0.13% 178
2020
Q3
$460K Sell
476
-118
-20% -$109K 0.13% 141
2020
Q2
$478K Sell
594
-162
-21% -$121K 0.13% 134
2020
Q1
$522K Buy
756
+16
+2% +$11.9K 0.15% 123
2019
Q4
$605K Buy
+740
New +$534K 0.11% 151

Other funds holding MTD

Exane Derivatives's MTD Position: Q2 2022 in Review

Exane Derivatives increased its Mettler-Toledo International (MTD) stake by 17% in Q2 2022, buying an estimated $74.1K and bringing the position to 413 shares worth $474K. The position accounts for 0.27% of the portfolio, ranked #91.

Exane Derivatives first reported a position in MTD in Q4 2019 and has held it in 11 quarters since. The position peaked at $760K in Q4 2021. 728 funds tracked by Wall St. Rank hold MTD as of Q2 2022.

  • Exane Derivatives held 413 shares of Mettler-Toledo International worth $474K as of Q2 2022.
  • Exane Derivatives bought 59 Mettler-Toledo International shares in Q2 2022, an estimated $74.1K.
  • Mettler-Toledo International made up 0.27% of Exane Derivatives's portfolio in Q2 2022, its #91 holding.
  • Exane Derivatives first reported a position in Mettler-Toledo International in Q4 2019 and has held it in 11 quarters since.
  • Exane Derivatives's Mettler-Toledo International position peaked at $760K in Q4 2021.
  • 728 funds tracked by Wall St. Rank held Mettler-Toledo International as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.